These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 36539215)

  • 1. Clinical Outcome Data of Children Treated with Cannabis-Based Medicinal Products for Treatment Resistant Epilepsy-Analysis from the UK Medical Cannabis Registry.
    Erridge S; Holvey C; Coomber R; Hoare J; Khan S; Platt MW; Rucker JJ; Weatherall MW; Beri S; Sodergren MH
    Neuropediatrics; 2023 Jun; 54(3):174-181. PubMed ID: 36539215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabis for the Treatment of Epilepsy: an Update.
    Gaston TE; Szaflarski JP
    Curr Neurol Neurosci Rep; 2018 Sep; 18(11):73. PubMed ID: 30194563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of CBD-enriched medical cannabis for treatment of refractory epilepsy in children and adolescents - An observational, longitudinal study.
    Hausman-Kedem M; Menascu S; Kramer U
    Brain Dev; 2018 Aug; 40(7):544-551. PubMed ID: 29674131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Updated Analysis of Clinical Outcome Measures Across Patients From the UK Medical Cannabis Registry.
    Ergisi M; Erridge S; Harris M; Kawka M; Nimalan D; Salazar O; Loupasaki K; Ali R; Holvey C; Coomber R; Usmani A; Sajad M; Beri S; Hoare J; Khan SA; Weatherall MW; Platt M; Rucker JJ; Sodergren MH
    Cannabis Cannabinoid Res; 2023 Jun; 8(3):557-566. PubMed ID: 35073160
    [No Abstract]   [Full Text] [Related]  

  • 5. Safety and pharmacokinetics of medical cannabis preparation in a monocentric series of young patients with drug resistant epilepsy.
    Gherzi M; Milano G; Fucile C; Calevo MG; Mancardi MM; Nobili L; Astuni P; Marini V; Barco S; Cangemi G; Manfredini L; Mattioli F; De Grandis E
    Complement Ther Med; 2020 Jun; 51():102402. PubMed ID: 32507423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabis, cannabidiol, and epilepsy--from receptors to clinical response.
    Szaflarski JP; Bebin EM
    Epilepsy Behav; 2014 Dec; 41():277-82. PubMed ID: 25282526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CBD-enriched medical cannabis for intractable pediatric epilepsy: The current Israeli experience.
    Tzadok M; Uliel-Siboni S; Linder I; Kramer U; Epstein O; Menascu S; Nissenkorn A; Yosef OB; Hyman E; Granot D; Dor M; Lerman-Sagie T; Ben-Zeev B
    Seizure; 2016 Feb; 35():41-4. PubMed ID: 26800377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective evaluation of oral cannabis extracts in children with epilepsy.
    Knupp KG; Rice JD; Helmkamp LJ; Galinkin J; Sempio C; Jost K; Chapman KE
    Seizure; 2019 Nov; 72():23-27. PubMed ID: 31550641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabis-based magistral formulation is highly effective as an adjuvant treatment in drug-resistant focal epilepsy in adult patients: an open-label prospective cohort study.
    Navarro CE
    Neurol Sci; 2023 Jan; 44(1):297-304. PubMed ID: 36129615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome.
    Hussain SA; Zhou R; Jacobson C; Weng J; Cheng E; Lay J; Hung P; Lerner JT; Sankar R
    Epilepsy Behav; 2015 Jun; 47():138-41. PubMed ID: 25935511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential Benefit of Add-on Δ9-Tetrahydrocannabinol in Pediatric Drug-Resistant Epilepsy: A Case Series.
    Nowicki M; Bourgeois-Tardif S; Diaz PL; Hebert FO; Sanon NT; Champagne PO; Major P; Sell E; Bitton J; Lewis E; Weil AG
    Can J Neurol Sci; 2022 Jul; 49(4):595-597. PubMed ID: 34183079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The current status of artisanal cannabis for the treatment of epilepsy in the United States.
    Sulak D; Saneto R; Goldstein B
    Epilepsy Behav; 2017 May; 70(Pt B):328-333. PubMed ID: 28254350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Observational study of medical marijuana as a treatment for treatment-resistant epilepsies.
    Devinsky O; Marmanillo A; Hamlin T; Wilken P; Ryan D; Anderson C; Friedman D; Todd G
    Ann Clin Transl Neurol; 2022 Apr; 9(4):497-505. PubMed ID: 35267245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term safety and efficacy of highly purified cannabidiol for treatment refractory epilepsy.
    Gaston TE; Ampah SB; Martina Bebin E; Grayson LP; Cutter GR; Hernando K; Szaflarski JP;
    Epilepsy Behav; 2021 Apr; 117():107862. PubMed ID: 33667843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoids in treatment-resistant epilepsy: A review.
    O'Connell BK; Gloss D; Devinsky O
    Epilepsy Behav; 2017 May; 70(Pt B):341-348. PubMed ID: 28188044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Outcome Data of First Cohort of Chronic Pain Patients Treated With Cannabis-Based Sublingual Oils in the United Kingdom: Analysis From the UK Medical Cannabis Registry.
    Kawka M; Erridge S; Holvey C; Coomber R; Usmani A; Sajad M; Platt MW; Rucker JJ; Sodergren MH
    J Clin Pharmacol; 2021 Dec; 61(12):1545-1554. PubMed ID: 34473850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of artisanal preparations of cannabidiol for the treatment of epilepsy: Practical experiences in a tertiary medical center.
    Porcari GS; Fu C; Doll ED; Carter EG; Carson RP
    Epilepsy Behav; 2018 Mar; 80():240-246. PubMed ID: 29429908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabidiol-enriched medical cannabis as add-on therapy in children with treatment-resistant West syndrome: A study of eight patients.
    Caraballo R; Valenzuela GR
    Seizure; 2021 Nov; 92():238-243. PubMed ID: 34624613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabidiol-enriched oil in children and adults with treatment-resistant epilepsy-does tolerance exist?
    Uliel-Sibony S; Hausman-Kedem M; Fattal-Valevski A; Kramer U
    Brain Dev; 2021 Jan; 43(1):89-96. PubMed ID: 32713661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use and caregiver-reported efficacy of medical cannabis in children and adolescents in Switzerland.
    Zürcher K; Dupont C; Weber P; Grunt S; Wilhelm I; Eigenmann DE; Reichmuth ML; Fankhauser M; Egger M; Fenner L
    Eur J Pediatr; 2022 Jan; 181(1):335-347. PubMed ID: 34309706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.